OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 11:14 (1231 d 04:58 ago) – Posting: # 20101
Views: 4,694

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
22,292 posts in 4,666 threads, 1,584 registered users;
online 12 (1 registered, 11 guests [including 4 identified bots]).
Forum time: Wednesday 17:12 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5